Yahoo Finance Site Map
ArticlesFor a comprehensive guide to our content, please see the Site Index
SiteMap 2024 > 12 > 10
Other dates of the month:
- Secret to AI profitability is hiring a lot more doctorates
- HireQuest, Inc. (HQI): A Bull Case Theory
- Target Corporation (TGT): A Bull Case Theory
- Intel Corporation (INTC): A Bull Case Theory
- Risk appetite is high and the bears are in retreat amid a dizzying market rally
- Immersion Corporation (IMMR): A Bull Case Theory
- Pool Corporation (POOL): A Bull Case Theory
- Unrealized Gains Taxes on Bitcoin…
- Republicans Already Feel Better About the Economy, While Democrats Dread What’s Ahead
- Victoria's Secret PINK makes big changes Gen Z will love
- Geotab and Logmaster collaborate to transform Australian trucking
- Undiscovered Gems And 2 More Small Caps with Promising Potential
- Jim Cramer on Ollie’s Bargain Outlet Holdings, Inc. (OLLI): ‘I Don’t Want To Get Off This Horse’
- Top Dividend Stocks To Consider In December 2024
- STATEMENT: With CUPW's national strike now in its fourth week, the union's latest offer takes major steps backwards
- MP Materials Announces Exchanges of a Portion of its 0.25% Green Convertible Senior Notes due 2026, Representing a Net Reduction of $25 Million of Outstanding Indebtedness
- BitRail Selected to Present at the Prestigious New England Venture Summit
- Why Baidu, Inc. (BIDU) Is Among the Best Autonomous Driving Stocks to Buy According to Hedge Funds
- Quobly announces key milestone for fault-tolerant quantum computing
- Trump Wants Truth Social Deal Lawsuit Put on Hold Over Immunity
- December 2024 Penny Stocks On The US Exchange To Watch
- Jim Cramer on Macy’s, Inc. (M): ‘Now Shareholders Are Entitled To Know What Really Happened Here’
- AMCON Distributing Company Acquires Arrowrock Supply
- Curbline (CURB) Stock: A Bull-Case Theory
- AeroVironment, Inc. (AVAV) Stock: A Bull-Case Theory
- Jim Cramer on AutoZone, Inc. (AZO): ‘I Used To Love It, I Can’t Load The Boat Up Here’
- AI Deals in 2024 Blow Past 2023 Investment at $55.3 Billion
- Struggling BRP Inc (DOOO) Stock Faces Tariff Threats
- ASBM Responds to PCMA: Put Patients First, Not PBM Profits
- Slowing Growth Casts A Shadow Over Mastercard’s (MA) Momentum
- Can SoundHound AI (SOUN) Achieve Profitability Without Compromising Growth?
- China launches an antitrust investigation into Nvidia as it wrestles with the US over AI chip sanctions
- ThreeD Capital Inc. Announces Unaudited November 30, 2024 Net Asset Value Per Share – $0.77
- PayPal’s (PYPL) Innovative Offerings Poised To Boost Its Future Prospects
- Jim Cramer on Toll Brothers, Inc. (TOL): ‘Can It Deliver On These Numbers? Is Lumber Price Too High? Well, We Won’t Have To Wait Too Long To Find Out’
- Legal Hurdles Can’t Slow Down Alphabet’s (GOOG) Growth
- Sirios Resources Announces Closing of a Second Tranche of $849,000 of its Flow-Through Private Placement
- The Odds Are Against Dynatrace (DT) In This Fierce Industry Race
- CRH PLC Stock: A Bullish Investment Perspective
- The Future of Energy Is in Your Pocket: Blow It Gum
- Carbon Dioxide Market is Slated to Develop at a Modest 5.1% CAGR through 2031 | SkyQuest Technology
- Industry Leaders Collaborate to Make the Transition to Confidential Computing Feasible. FMI Forecasts USD 692 billion Market Valuation by 2034 | Future Market Insights, Inc.
- Australia’s Business Confidence Slumps in Bad Omen for Economy
- Immune-Onc Therapeutics Presents Updated Data from Phase 1b Study of IO-202 Highlighting Promising Efficacy and Safety Data in CMML Patients at 2024 American Society of Hematology (ASH) Annual Meeting
- New and Updated Data for Genentech’s Fixed-Duration Columvi and Lunsumio at ASH 2024 Reinforce Their Potential to Improve Outcomes for People With Lymphoma
- SSC Security Services Corp. Announces FY2024 Year End Results: 18% Adjusted EBITDA per Share growth on 11% Revenue Growth, Buys Back another 3% of the Company
- CARVYKTI® (ciltacabtagene autoleucel) demonstrated significantly higher rates of minimal residual disease (MRD) negativity compared to standard therapies in the CARTITUDE-4 study
- Antengene Presents Results from Two Late-Stage Clinical Studies of Selinexor at ASH 2024
- SSC Security Services Corp. Announces Thirty Third Dividend Payment
- SSC Security Services Corp. Announces Intention to Renew Normal Course Issuer Bid